BCEIE › News › KRSNAA

Fund raising

Krsnaa Diagnostics approves warrants

Krsnaa Diagnostics (KRSNAA) said it has approved warrants. The company is valued at about ₹1,793 crore.

BCEIE News Desk · Published 8 Oct 2026, 09:30 pm IST · Filing received 8 Oct 2026, 09:15 pm IST

What happened

In a filing with the BSE on 8 October 2026 at 09:15 PM, Krsnaa Diagnostics (KRSNAA) said that it has approved warrants.

Company snapshot

Krsnaa Diagnostics is a small-cap company, with a market value of about ₹1,793 crore.

The stock last traded at ₹552.7, against a 52-week range of ₹515–₹848.1 (34.8% below the high).

Before this filing the shares had moved −1.3% over the month and +1.4% over three months. Average daily turnover over the last 20 sessions was about ₹12.64 crore.

Promoters held 27.11% at the end of Q1 FY27. Foreign institutions owned 4.28% and domestic institutions 14.51%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2619320.56.35
Q2 FY2620623.97.38
Q3 FY2618115.24.72
Q4 FY2619341.712.86
Q1 FY2723616.65.1

What history shows

BCEIE's records show 2 previous fund raising filings from the company since May 2026.

After those filings, the stock gained 2.5% on average the next trading day and was up 2.5% on average after five days (2 filings with price data).

Market-wide, 1,541 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 48% rising.

Past reactions describe what happened before; they are not a forecast.

Earlier filings of this kind
DateFilingNext day5 days
20 Aug 2026Fund raising+4.8%+4.0%
13 Aug 2026A press release dated August 13, 2026, titled "Promoters Back the…+0.3%+0.9%

What to watch

  • How the money raised is used and, for equity instruments, the dilution for existing shareholders.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Krsnaa Diagnostics Limited